medigraphic.com
ISSN 1025-0255 (Electronic)

2016, Number 3

<< Back Next >>

AMC 2016; 20 (3)

Nodular thyroid disease incidence and correlation cytohistological

Rojo QN, Suárez SBG, Rondón ME, Durruthy WO, Valladares LR

Language: Spanish
References: 30
Page: 299-308
PDF size: 662.42 Kb.


ABSTRACT

Background: thyroid nodular disease is of frequent medical consultation, so it should be evaluated carefully in order to make the right treatment at the right time.
Objective: to determine the incidence of nodular thyroid disease and cytohistological correla-tion at the University Hospital "Manuel Ascunce Domenech" during the period from January 2013 to December 2014.
Methods: a cross-sectional descriptive study was conducted. The universe was composed of 139 patients diagnosed with thyroid nodule treated at the aforementioned charitable institution during the period before indicated. The sample consisted of equal numbers of patients.
Results: the most common age group was that of 40-49 years. The disease was more frequent in females (87.8%). The multinodular lesions (70.5%) prevailed over the only nodular (29.5%). Most patients were classified as category II of Bethesda (52.5%). Paraffin biopsy identified benign lesions, multinodular goitre was the most reported (25.9%) and among malignant papillary carcinoma (16.5%).
Conclusions: there was relationship between classes I-IV with multinodular lesions and nodular lesions only with the V-VI classes. The analysis of the data showed that the fine needle biopsy is a highly sensitive for the detection of malignancy test. It also showed that this test has a high negative predictive value.


REFERENCES

  1. Selek A, Cetinarslan B, Kivrakoglu E, Karadag DT, Tarkun I, Canturk Z, et al. Histologic outcome of thyroid nodules with repeated diag-nosis of atypia in thyroid fine-needle aspiration biopsy. Future Oncol. 2016 Feb;12(6):801-805.

  2. Benvenga S, Antonelli A, Vita R. Thyroid nod-ules and thyroid autoimmunity in the context of environmental pollution. Rev Endocr Metab Disord [Internet]. 2015 Dec [citado 2016 Mar 7];16(4):[aprox. 12 p.]. Disponible en: http://link.springer.com/article/10.1007%2Fs11154-016-9327-6

  3. Teng S, Jia Q, Huang Y, Chen L, Fei X, Wu J. Hierarchical regionalization for spatial epidemiol-ogy: a case study of thyroid cancer incidence in Yiwu, Zhejiang. Zhonghua Liu Xing Bing Xue Za Zhi. 2015 Oct;36(10):1142-7.

  4. Lin CM, Yeh PT, Doyle P, Tsan YT, Chen PC. Association between 131I treatment for thyroid cancer and risk of receiving cataract surgery-a cohort study from Taiwan. J Nucl Med. 2016 Jun;2(115):167-97.

  5. Sierra Fonseca RM, Escalona Veloz R, Galano Stivens E, Cogle Duvergel YY, Medina Tola J. Comparación entre los resultados citológicos e histológicos de pacientes con afecciones tiroideas. MEDISAN [Internet]. Jun 2014 [citado 7 Mar 2016];18(6):[aprox. 7 p.]. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192014000600013&lng=es

  6. Bi Y, Meng Y, Wu H, Cui Q, Luo Y, Xue X. Ex-pression of the potential cancer stem cell mark-ers CD133 and CD44 in medullary thyroid carci-noma: A ten-year follow-up and prognostic anal-ysis. J. Surg. Oncol. 2016 Feb;113(2):144-51.

  7. Lin Z, Lu X, Li W, Sun M, Peng M, Yang H, et al. Association of Cancer Stem Cell Markers With Aggressive Tumor Features in Papillary Thyroid Carcinoma. Cancer Control. 2015 Oct;22(4):508-14.

  8. Iglesias Díaz G, García García IN, Correa Martínez L. Características clínico epidemiológicas de pacientes operados de bocio coloide reintervenidos por recidiva. MediSur [Internet]. 2015 [citado 7 Mar 2016];13(5):[aprox. 7 p.]. Disponible en: http://medisur.sld.cu/index.php/medisur/article/view/2937

  9. Ignacio Chala A, Ignacio Franco H, Darío Aguilar C, Paulo Cardona J. Estudio descriptivo de doce años de cáncer de tiroides, Manizales, Colombia. Rev Colombiana Cir [Internet]. 2010 [citado 7 Mar 2016];25(4): [aprox. 12 p.]. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_abstract&pid=S2011-75822010000400003&lng=es

  10. Richmond BK, Judhan R, Chong B, Ubert A, AbuRahma Z, Mangano W, et al. False-negative results with the Bethesda System of reporting thyroid cytopathology: predictors of malignancy in thyroid nodules classified as benign by cyto-pathologic evaluation. Am Surg. 2014 Aug;80(8):811-6.

  11. Romero Rojas A, Melo Uribe MA. Implementación del Sistema Bethesda para el informe de citología aspirativa de tiroides con seguimiento histopatológico: experiencia en un centro de tratamiento de cáncer. Rev Colomb Cancerol [Internet]. Ene-Mar 2014 [citado 1 feb 2016];18(1):[aprox 4 p.]. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0123-90152014000100002&nrm=iso

  12. Sarkis LM, Norlen O, Aniss A, Watson N, Del-bridge LW, Sidhu SB, et al. The Australian expe-rience with the Bethesda classification system for thyroid fine needle aspiration biopsies. Pathology. 2014 Dic;46(7):592-5.

  13. Dorimain PC, Rodríguez Fernández Z, Rodríguez Sánchez LP, Falcón Vilariño GC, Mustelier Ferrer HL. Diagnóstico y tratamiento quirúrgico de pacientes con afecciones nodulares de tiroides. MEDISAN [Internet]. Nov 2013 [citado 1 Feb 2016];17(11):[aprox 11 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192013001100008&nrm=iso

  14. Anand A, Singh KR, Kushwaha JK, Hussain N, Sonkar AA. Papillary Thyroid Cancer and Hashimoto's Thyroiditis: An Association Less Un-derstood. Indian J Surg Oncol. 2014 Sep;5(3):199-204.

  15. Azizi G, Keller JM, Lewis M, Piper K, Puett D, Rivenbark KM, et al. Association of Hashimoto's thyroiditis with thyroid cancer. Endocr Relat Cancer. 2014;21(6):845-52.

  16. Ehlers M, Schott M. Hashimoto's thyroiditis and papillary thyroid cancer: are they immuno-logically linked?. Trends Endocrinol Metab. 2014 Dic;25(12):656-64.

  17. Alabdulqader NA, Shareef SQ, Ali JA, Yousef MM, Al-Abbadi MA. Application of the Bethesda System for Reporting Thyroid Cytopathology in the Eastern Province of Saudi Arabia: A Follow-Up Study. Acta Cytol. 2015;59(3):233-8.

  18. Deniwar A, Hambleton C, Thethi T, Moroz K, Kandil E. Examining the Bethesda criteria risk stratification of thyroid nodules. Pathol Res Pract. 2015 May;211(5):345-8.

  19. Arul P, Masilamani S. A correlative study of solitary thyroid nodules using the bethesda sys-tem for reporting thyroid cytopathology. J Can-cer Res Ther. 2015 Jul-Sep;11(3):617-22.

  20. Li Z, Franklin J, Zelcer S, Sexton T, Husein M. Ultrasound surveillance for thyroid malignan-cies in survivors of childhood cancer following radiotherapy: a single institutional experience. Thyroid. 2014 Dic;24(12):1796-805.

  21. Papini E, Pacella CM, Misischi I, Guglielmi R, Bizzarri G, Dossing H, et al. The advent of ultra-sound-guided ablation techniques in nodular thy-roid disease: towards a patient-tailored ap-proach. Best Pract Res Clin Endocrinol Metab. 2014 Aug;28(4):601-18.

  22. Arpaci D, Ozdemir D, Cuhaci N, Dirikoc A, Kilicyazgan A, Guler G, et al. Evaluation of cyto-pathological findings in thyroid nodules with macrocalcification: macrocalcification is not inno-cent as it seems. Arq Bras Endocrinol Metabol. 2014 Dic;58(9):939-45.

  23. Aydin H, Arda K. Do intranodular macrocalci-fications really play an important role in so-nographic prediction of malignancy? Yonsei Med J. 2014 Sep;55(5):1450-1.

  24. Yoo JY, Stang MT. Current Guidelines for Postoperative Treatment and Follow-Up of Well-Differentiated Thyroid Cancer. Surg Oncol Clin N Am. 2016 Ene;25(1):41-59.

  25. Wilson RJ, Ryerson AB, Singh SD, King JB. Cancer Incidence in Appalachia, 2004-2011. Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):250-8.

  26. Yamada K, Tanaka S, Hiratsuka Y, Kumabe Y, Watanabe Y, Yoshida T, et al. Prognosis of Pa-pillary Thyroid Carcinoma with Local Invasion. Nihon Jibiinkoka Gakkai Kaiho. 2015 Feb;118(2):115-22.

  27. Norlen O, Charlton A, Sarkis LM, Henwood T, Shun A, Gill AJ, et al. Risk of malignancy for each Bethesda class in pediatric thyroid nodules. J Pediatr Surg. 2015 Jul;50(7):1147-9.

  28. Melo Uribe MA, Sanabria A, Romero Rojas A, Pérez G, Vargas EJ, Abaunza MC, et al. The Be-thesda system for reporting thyroid cytopatholo-gy in Colombia: Correlation with histopathologi-cal diagnoses in oncology and non-oncology in-stitutions. J Cytol. 2015 Ene-Mar;32(1):12-6.

  29. Yoo MR, Gweon HM, Park AY, Cho KE, Kim JA, Youk JH, et al. Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next? PLoS One. 2015;10(6):130-8.

  30. Straccia P, Rossi ED, Bizzarro T, Brunelli C, Cianfrini F, Damiani D, et al. A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated? Cancer Cytopathol. 2015 Dic;123(12):713-22.




2020     |     www.medigraphic.com